CDLX Cardlytics Inc

  1. Stocks
  2. Technology
  3. NASDAQ: CDLX

Price (delayed)

$120.45

Market cap

$3.31B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.62

Enterprise value

$3.2B

Sector: Technology
Industry: Internet Content & Information
Website: https://www.cardlytics.com/

Highlights

The company's quick ratio has surged by 133% YoY and by 80% QoQ
Cardlytics's equity has increased by 18% YoY and by 15% from the previous quarter
The net income has contracted by 41% YoY and by 20% from the previous quarter
The EPS has declined by 17% since the previous quarter and by 16% year-on-year

Key stats

What are the main financial stats of CDLX
Market
Shares outstanding
27.46M
Market cap
$3.31B
Enterprise value
$3.2B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
21.86
Price to sales (P/S)
17.42
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
16.95
Earnings
Revenue
$189.1M
EBIT
-$45.52M
EBITDA
-$35.72M
Free cash flow
-$19.98M
Per share
EPS
-$1.62
Free cash flow per share
-$0.73
Book value per share
$5.51
Revenue per share
$6.92
TBVPS
$14.02
Balance sheet
Total assets
$389.42M
Total liabilities
$239.06M
Debt
$184.51M
Equity
$150.36M
Working capital
$295.69M
Liquidity
Debt to equity
1.23
Current ratio
6.08
Quick ratio
5.95
Net debt/EBITDA
2.89
Margins
EBITDA margin
-18.9%
Gross margin
34.7%
Net margin
-23.9%
Operating margin
-24.6%
Efficiency
Return on assets
-18%
Return on equity
-32.2%
Return on invested capital
-50.1%
Return on capital employed
-13.7%
Return on sales
-24.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CDLX stock price

How has the Cardlytics stock price performed over time
Intraday
-3.5%
1 week
3.18%
1 month
-15.78%
1 year
36.88%
YTD
-15.63%
QTD
-15.63%

Financial performance

How have Cardlytics's revenue and profit performed over time
Revenue
$189.1M
Gross profit
$65.59M
Operating income
-$46.55M
Net income
-$45.22M
Gross margin
34.7%
Net margin
-23.9%
The operating income has dropped by 58% year-on-year and by 26% since the previous quarter
Cardlytics's operating margin has shrunk by 58% YoY and by 32% QoQ
The net income has contracted by 41% YoY and by 20% from the previous quarter
The net margin has contracted by 41% YoY and by 26% from the previous quarter

Growth

What is Cardlytics's growth rate over time

Valuation

What is Cardlytics stock price valuation
P/E
N/A
P/B
21.86
P/S
17.42
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
16.95
The EPS has declined by 17% since the previous quarter and by 16% year-on-year
The price to book (P/B) is 93% higher than the last 4 quarters average of 11.3
Cardlytics's equity has increased by 18% YoY and by 15% from the previous quarter
The stock's price to sales (P/S) is 123% more than its last 4 quarters average of 7.8
CDLX's revenue is down by 5% since the previous quarter

Efficiency

How efficient is Cardlytics business performance
The return on sales has declined by 47% year-on-year and by 27% since the previous quarter
The ROIC has grown by 43% from the previous quarter but it has contracted by 13% YoY
The ROE rose by 32% YoY but it fell by 15% QoQ
The company's return on assets rose by 11% YoY and by 3.2% QoQ

Dividends

What is CDLX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDLX.

Financial health

How did Cardlytics financials performed over time
The total assets is 63% greater than the total liabilities
The company's quick ratio has surged by 133% YoY and by 80% QoQ
Cardlytics's current ratio has soared by 131% YoY and by 76% from the previous quarter
The debt is 23% more than the equity
Cardlytics's equity has increased by 18% YoY and by 15% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.